Business & Finance

Bentley Pharmaceuticals experiences 7% revenue growth

Published in Law and Health Weekly, December 9th, 2006

Bentley Pharmaceuticals, Inc., (BNT), a specialty pharmaceutical company, announced that Bentley experienced 7% revenue growth when compared to the same quarter of a year ago with record third quarter sales of $25.2 million.

The company incurred charges of $8.9 million in litigation costs, as well as severance and other executive termination charges of $600,000. This contributed to a loss of $7.2 million for the quarter compared to net income of $2.5 million reported in the third quarter of 2005. The loss per share for the 2006 quarter was $0.33, compared to earnings per share of $0.11 for the 2005 quarter.

"During the third quarter, we sustained...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2006-12-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry